{"id":10737,"date":"2020-05-06T17:39:33","date_gmt":"2020-05-06T15:39:33","guid":{"rendered":"https:\/\/fedegari.com\/?p=10737"},"modified":"2020-09-15T15:08:07","modified_gmt":"2020-09-15T13:08:07","slug":"wuxi-biologics-chooses-fedegari-in-ireland","status":"publish","type":"post","link":"https:\/\/fedegari.com\/en\/wuxi-biologics-chooses-fedegari-in-ireland\/","title":{"rendered":"WuXi Biologics chooses Fedegari in Ireland"},"content":{"rendered":"

[vc_row full_width=”stretch_row_content_no_spaces” equal_height=”yes” content_placement=”middle” css=”.vc_custom_1551448839631{background-color: #eaedf2 !important;}”][vc_column width=”1\/2″ css=”.vc_custom_1588781951921{background-image: url(https:\/\/fedegari.com\/wp-content\/uploads\/2020\/05\/wuxi_biologcs_fedegari_autoclave_sterilizer_sterilization.jpg?id=10869) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” offset=”vc_hidden-xs”][\/vc_column][vc_column width=”1\/2″][vc_row_inner css=”.vc_custom_1551447616941{padding-right: 30px !important;padding-left: 30px !important;}”][vc_column_inner width=”1\/6″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_empty_space height=”40px”][vc_column_text]<\/p>\n

HOME<\/a> <\/i><\/b><\/span><\/span>\u00a0NEWS<\/span><\/a><\/b><\/span><\/h5>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css_animation=”fadeIn”]<\/p>\n

WUXI BIOLOGICS<\/strong><\/h1>\n

chooses Fedegari for its largest bio-manufacturing facility in Ireland<\/strong><\/h1>\n

WuXi Biologics<\/a>, Chinese world leader in the production of biotech pharmaceuticals,<\/strong> has chosen Fedegari Group to supply 15 high-performance<\/strong> process machines – GMP washers and autoclaves<\/strong> – for its new production<\/strong> site in Ireland.<\/em>[\/vc_column_text][vc_empty_space height=”20px”][\/vc_column_inner][vc_column_inner width=”1\/6″][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” equal_height=”yes” css=”.vc_custom_1551448777969{margin-top: 60px !important;margin-bottom: 60px !important;}” el_id=”content”][vc_column width=”1\/2″][vc_empty_space height=”5px”][vc_empty_space height=”5px”][vc_column_text css_animation=”fadeIn”]<\/p>\n

“We are all excited to initiate our first global site to enable local companies and expedite biologics development in Europe. In addition, this is the start and a critical part of our global biomanufacturing network to ensure that biologics are manufactured at the highest quality and with a robust supply chain to benefit patients worldwide. We will work with all local partners to build this state-of-art next generation biomanufacturing facility as a showcase to the global biotech community.”\u00a0 said Dr. Chris Chen, CEO of WuXi Biologics.<\/p><\/blockquote>\n

[\/vc_column_text][vc_empty_space height=”20px”][vc_empty_space height=”20px”][vc_empty_space height=”20px”][vc_column_text css_animation=”fadeIn”]<\/p>\n

NEW PLANT<\/h2>\n

The new headquarters to be inaugurated in Dundalk<\/a> will receive investments of 325 MEUR and the construction will provide the employment of 700 people with the creation of 600 new jobs by 2024. The manufacturing project in a 26-hectare campus, the company’s first site outside of\u00a0China, is supported by the Irish Government through IDA\u00a0Ireland[\/vc_column_text][vc_empty_space height=”20px”][vc_empty_space height=”5px”][vc_single_image image=”10837″ img_size=”full” add_caption=”yes”][vc_empty_space height=”5px”][vc_empty_space height=”5px”][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner offset=”vc_hidden-xs”][vc_single_image image=”10864″ img_size=”full” add_caption=”yes” css_animation=”fadeIn” css=”.vc_custom_1588778423734{background-image: url(https:\/\/fedegari.com\/wp-content\/uploads\/2020\/03\/Linea-di-produzione-Grintuss.jpg?id=10161) !important;}”][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”10px”][vc_empty_space height=”10px”][vc_empty_space height=”10px”][vc_column_text]<\/p>\n

BIOMANUFACTURING<\/h2>\n

Wuxi\u2019s state-of-the-art facility will employ multiple single-use bioreactors for commercial biomanufacturing and is designed to be able to run continuous bioprocessing, a next generation manufacturing technology to be first implemented globally in this campus. A total of 48,000 l fed-batch and 6,000 l perfusion bioreactor capacity will be installed, representing the world’s largest facility using single-use bioreactors.[\/vc_column_text][vc_empty_space height=”10px”][vc_column_text]<\/p>\n

“The global bio\/pharma market is changing, and we are experiencing an ever-growing interest in our business model. The pre-requisite for introducing more cost-effective and reliable drug manufacturing solutions is a strong technical partnership between end-users and, equipment suppliers. Without a rock-solid relationship of trust, the end-users will not dare to invest in unconventional solutions. However, this relationship will not develop out of bombastic statements on a website rather is the consequence of a tested technical relationship\u201d, said Giuseppe Fedegari, President of the group.<\/p><\/blockquote>\n

[\/vc_column_text][vc_empty_space height=”10px”][vc_empty_space height=”10px”][vc_empty_space height=”10px”][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” equal_height=”yes” css=”.vc_custom_1551448777969{margin-top: 60px !important;margin-bottom: 60px !important;}”][vc_column width=”1\/2″][vc_empty_space height=”5px”][vc_column_text css_animation=”fadeIn”]<\/p>\n

GMP WASHERS & STERILIZERS<\/h2>\n

The collaboration between Fedegari and WuXi began in China in 2018. The new project in Ireland strengthens the relationship with the supply of 8 high- performance sterilizers and 7 eco-steam washers for a value of about 4 MEUR.<\/p>\n

This agreement consolidates Fedegari presence in the Asian market, which corresponds to 30% of the company revenues.<\/p>\n